Andera Partners

Andera Partners is a private equity firm focused on early- and late-stage venture investments.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Andera Partners Information

Geographic Data

Andera Partners headquarters map

Address: 374 rue Saint Honoré

City: Paris

State: île-de-france

Zip: 75001

Country: FR

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$1B

Metrics

1,200,227Website Global Rank

24,250Website Monthly Traffic

Twitter Followers

Description

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas: Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
7/2019 Travelsoft Private Equity Round -
11/2017 walor Private Equity Round -
7/2017 Groupe 3S Private Equity Round -
9/2012 Alouette Private Equity Round -
10/2018 Groupe JORYF Private Equity Round -
1/2010 Smile Venture Round 3.6M
1/2019 Exciva Seed Round -
7/2017 Studia group Private Equity Round -
5/2015 Altavia Venture Round -
12/2018 T-knife Seed Round 9.1M
4/2008 AJ Tech Series A 1.3M
9/2017 Intech Private Equity Round -
8/2020 ReViral Series C 0
9/2012 DEFI Group Private Equity Round -
7/2018 orbility Private Equity Round -
9/2015 Pennel &a; Flipo Private Equity Round -
12/2019 Opportunity Private Equity Round -
11/2014 A2IA Private Equity Round -
3/2016 La Toulousaine Private Equity Round -
7/2016 Ipside Venture Round 3.3M
5/2020 Arvelle Therapeutics Series A 0
7/2010 Poxel Series A 21M
6/2018 Tricares Series B 25.7M
2/2010 PDC Biotech Series A 5.5M
4/2019 Tournus Equipement Private Equity Round -
1/2021 Sirsa Venture Round -
1/2023 Amolyt Pharma Series C 0
6/2009 Implanet Series B 12.6M
9/2017 La Vie Saine Private Equity Round -
7/2016 Fortesan Venture Round 16.7M
9/2021 Amolyt Pharma Series B 0
4/2016 MedDay Series B 0
4/2018 Crescendo Biologics Series B 0
8/2018 Artios Pharma Series B 0
10/2006 Domain Therapeutics Series C 10.4M
6/2017 Minafin Private Equity Round -
12/2009 Regado Biosciences Series D 0
10/2008 SuperSonic Imagine Series B 25.7M
2/2006 MeeVee Series B 6.5M
4/2013 Allecra Therapeutics Series A 19.6M
2/2020 JenaValve Technology Series D 0
4/2010 Genticel Series C 17.7M
8/2014 Groupe ADF Private Equity Round -
11/2011 In2Bones France Seed Round 1.4M
12/2018 INNOVO by Atlantic Therapeutics Private Equity Round -
9/2015 Groupe ERGET Venture Round -
3/2022 Kyotherm Venture Round 0
1/2007 Novexel Series B 65M
6/2022 ImCheck Therapeutics Series C 0
9/2009 Santen Pharmaceutical Post-IPO Equity 22M
12/2012 Poxel Series B 17.2M
5/2014 Chase Pharmaceuticals Series B 21M
7/2018 Dynacure Series A 55.2M
4/2020 Dynacure Series C 54.2M
9/2010 Garden Price Venture Round 2.7M
2/2006 Cytomics Pharmaceuticals Series B 11.9M
3/2005 Nautilus Biotech Venture Round 0
8/2015 JenaValve Technology Series C 26.5M
6/2015 Realeve Series D 43.2M
7/2013 JenaValve Technology Series C 62.5M
6/2010 JenaValve Technology Series B 22.7M
1/2013 Unitedcoatings Group Venture Round 0
3/2017 Medlumics Series B 36.9M
2/2022 Lhyfe Venture Round 0
1/2011 OCEAN SAS Venture Round -
6/2016 Allecra Therapeutics Series B 24.8M
2/2021 Medlumics Venture Round 21.8M
7/2021 Klubb Venture Round -
2/2022 TargED Biopharmaceuticals Series A 0
4/2023 BioVentrix Series A 0
1/2023 SoniVie Series C 0
10/2022 Senstronic Venture Round -
1/2023 Grey Wolf Therapeutics Series B 0
6/2019 SANIFIT Series D 0
11/2013 Endosense Series C 41.2M
2/2016 Sogetrel Private Equity Round -
12/2001 Genome Express Series B 0
9/2019 Inotrem Series B 43.1M
7/2021 Artios Pharma Series C 0
10/2015 REALEASE Capital Private Equity Round -
10/2012 ProwebCE Venture Round -
6/2005 Cellectis Series C 6.8M
6/2007 Exclusive Group Venture Round 4M
3/2021 INNOVO by Atlantic Therapeutics Venture Round -
5/2002 Cellectis Series B 7.2M
4/2023 Ariceum Therapeutics Series A 0
10/2021 Exciva Series A 0
1/2019 HighLife Series B 36M
12/2014 Emeraude International Private Equity Round -
5/2017 Axonics Modulation Technologies Series C 0
4/2006 Santen Pharmaceutical Post-IPO Equity 31.5M
7/2019 AM Pharma Series F 130.1M
1/2019 INNOVO by Atlantic Therapeutics Series B 32.1M
10/2017 Globe Groupe Private Equity Round -
9/2015 SANIFIT Series C 0
11/2010 SuperSonic Imagine Series C 0
10/1999 Drug Abuse Sciences Venture Round 22.4M
10/2014 Thomson Video Networks Private Equity Round -
9/2016 MS Vacances Venture Round 13.5M
6/2018 ENYO Pharma Series B 46.8M
8/2011 Vessix Vascular Series B 0
4/2015 ACE Group Venture Round -
8/2020 T-knife Series A 78.4M
9/2015 ReViral Series A 21M
11/2012 Endosense Series C 40.3M
7/2016 Mondial Pet Distribution Venture Round 16.6M
7/2012 Medcdtll Venture Round -
9/2004 Santen Pharmaceutical Post-IPO Equity 11.2M
5/2010 Noxxon Pharma Series D 40.7M
6/2011 Sapiens Steering Brain Stimulation Series A 18.7M
4/2019 HR Path Private Equity Round 112.4M
2/2005 MeeVee Series A 7M
11/2021 ImmoCity Venture Round -
11/2017 erytech Post-IPO Equity -
7/2016 Atland Venture Round 3.3M
11/2009 Vivoryon Therapeutics Series B 0
11/2014 Finsecur Venture Round 31.2M
1/2012 Vivoryon Therapeutics Venture Round 19.4M
5/2007 Implanet Series A 17.7M
12/2019 Mastergrid Private Equity Round -
1/2011 Novamex SA Private Equity Round -
10/2014 Maesa Group Venture Round -
12/2018 The Bioclinic Group Private Equity Round -
6/2013 MCI Group Holding Private Equity Round -
6/2013 Complix Series B 15.6M
3/2015 Ace Credit Private Equity Round -
12/2018 Solware Group Private Equity Round -
4/2017 Bacacier group Private Equity Round -
2/2018 Biogroup-LCD Debt Financing -
11/2016 NetCo Venture Round -
5/2004 Domain Therapeutics Series B 19.1M
6/2015 Rougnon Private Equity Round -
5/2019 SPHEREA Venture Round -
5/2007 Noxxon Pharma Series C 50.2M
9/2017 Loyalty Company Venture Round -
11/2007 EOS Imaging Venture Round 18M
3/2014 Inotrem Series A 25.1M
9/2014 Poxel Series B 13.5M
6/2017 LogicBio Therapeutics Series B 45M
10/2007 Fastbooking Venture Round 50.4M
10/2016 The Reefer Group Private Equity Round -
7/2010 Implanet Series D 10.1M
1/2013 ITESA Private Equity Round -
2/2020 JenaValve Technology Venture Round 50M
3/2014 Axonics Modulation Technologies Series A 32.6M
4/2014 Passman Private Equity Round -
1/2020 Grey Wolf Therapeutics Series A 3.3M
7/2022 Resonance Imaging Group Venture Round -
2/2011 CellNovo Series B 48.3M
8/2018 ReViral Series B 0
7/2017 Complexa Series C 62M
3/2023 FIRE1 Venture Round 0
6/2016 Verona Pharma Post-IPO Equity 65.6M
2/2019 Grey Wolf Therapeutics Series A 12.9M
6/2022 Mineralys Therapeutics Series B 0
5/2022 HR Path Private Equity Round 0
2/2019 Arvelle Therapeutics Series A 0
9/2022 Tricares Series C 0
9/2007 MeeVee Series D 3.5M
4/2018 MMI Series A 24.8M
7/2022 MMI Series B 0
1/2015 Genkyotex Post-IPO Equity 0
1/2016 Sfam Private Equity Round -
12/2015 GamaMabs Pharma Series B 16.4M
12/2012 Regado Biosciences Series E 0
5/2011 Genkyotex Series C 20.4M
11/2010 Covagen Series A 6.3M
7/2012 Genkyotex Series C 25.6M
12/2013 Covagen Series B 0
8/2021 T-knife Series B 110M
8/2022 JenaValve Technology Series C 0
5/2022 Tubulis Series B 0
4/2010 Implanet Series C 10.8M
8/2013 OncoEthix Series B 0
1/2017 Avalyn Pharma Series A 0
5/2017 Genoa Pharmaceuticals Series A 62M
5/2023 Dualyx Series A 0
3/2020 AM Pharma Venture Round 25.4M
10/2009 Endosense Series B 0
5/2015 Realeve Series D 38M
4/2018 Corvidia Series B 60M
12/2015 Axonics Modulation Technologies Series B 0
3/2021 AgomAb Therapeutics Series B 0
9/2021 Evommune Series A 83M
4/2023 Evommune Series B 50M
7/2011 Sun City Group, Inc. Venture Round -
4/2013 Genticel Series D 23.7M
4/2023 Ariceum Therapeutics Series A 0
4/2023 BioVentrix Series A 0
3/2023 FIRE1 Venture Round 0
1/2023 Grey Wolf Therapeutics Series B 0
1/2023 SoniVie Series C 0
1/2023 Amolyt Pharma Series C 0
10/2022 Senstronic Venture Round -
9/2022 Tricares Series C 0
8/2022 JenaValve Technology Series C 0
7/2022 MMI Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research
CoBee's Logo
Copyright © CoBee 2022. All Rights Reserved.